{
    "nctId": "NCT05910398",
    "briefTitle": "Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive HER2-positive Breast Cancer",
    "officialTitle": "Continuous or Intermittent Extension of Adjuvant Pyrotinib for Invasive Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer: a Prospective, Randomised, Controlled, Multicentre Clinical Trial",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer Invasive",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 488,
    "primaryOutcomeMeasure": "Invasive Disease-free Survival (iDFS)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Aged \u226518 and \u226470 years;\n* Histologically confirmed invasive HER2 positive breast cancer;\n* Duration from random time to the last use of trastuzumab or T-DM1 \u22643 years;\n* Performance Status- Eastern Cooperative Oncology Group (ECOG) 0-1;\n* Adequate organ functions.\n\nExclusion Criteria:\n\n* Metastatic disease (Stage IV);\n* Gross residual disease remaining after mastectomy or positive margins after breast-conserving surgery;\n* Subjects that are unable to swallow tablets, or dysfunction of gastrointestinal absorption;\n* Treated or treating with anti-HER2 tyrosine kinase inhibitor;\n* Less than 4 weeks from the last clinical trial;\n* History of immunodeficiency, including HIV-positive, suffering from other acquired, congenital immunodeficiency disease, or history of organ transplantation;\n* Female patients who are pregnancy, lactation or women who are of childbearing potential tested positive in baseline pregnancy test; Female patients of childbearing age that are reluctant to take effective contraceptive measures throughout the trial period;\n* Evidence of significant medical illness that in the investigator's judgment will substantially increase the risk associated with the subject's participation in and completion of the study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}